Sleep Apnea During Pregnancy: How It Impacts Your Baby's Growth
"New research reveals the surprising link between mild sleep apnea in pregnant women and accelerated fetal growth. Is your baby at risk?"
Obstructive sleep apnea (OSA), a condition characterized by repeated interruptions in breathing during sleep, is becoming increasingly prevalent during pregnancy. While the link between OSA and maternal health issues like gestational diabetes and hypertensive disorders is well-established, the impact on the developing fetus is an area of ongoing research.
A recent study published in Scientific Reports sheds new light on this topic. Researchers investigated the relationship between maternal OSA and fetal growth in non-obese pregnant women, utilizing objective assessment tools to minimize confounding factors such as maternal obesity and pregnancy complications. The results revealed a surprising connection: even mild OSA may be associated with accelerated fetal growth.
This article breaks down these findings, explaining what they mean for expectant mothers and their babies. We'll explore the potential mechanisms behind this link and discuss what steps you can take to promote a healthy pregnancy.
Current Study Approaches
The Sleep Apnea and Fetal Growth Restriction (SAFER) study is a multicentre, pragmatic trial conducted in a tertiary care setting. It focuses on patients with both fetal growth restriction and home sleep apnoea testing-diagnosed obstructive sleep apnoea (OSA), increasing the potential benefit of intervention while limiting generalisability. The study proposed positive airway pressure as an antenatal therapy for fetal growth restriction in maternal OSA. Other research has used retrospective reviews of pregnant women who underwent overnight polysomnography and sonographic fetal-growth assessment.
Foundations of the Evidence
Fetal growth restriction has long been recognized as a pregnancy complication with maternal, placental, or fetal causes. Research into maternal sleep-disordered breathing has expanded, but the literature remains highly heterogeneous in how breathing disorders are identified, when testing occurs, and how abnormal fetal or neonatal growth is defined. Animal models indicate that intermittent hypoxia can cause abnormal fetal growth, whereas human studies have reported conflicting associations. One case-control study reported that maternal OSA was independently associated with altered fetal growth and that the association appeared to be ameliorated with positive airway pressure.
Mild Sleep Apnea: What the Study Revealed
The study, led by Ayana Telerant and colleagues, involved 155 non-obese pregnant women. Researchers carefully controlled for factors like obesity and pregnancy complications to isolate the effects of OSA. Here's what they discovered:
- Birth Length: Measurements were significantly higher in newborns whose mothers had OSA.
- Triceps Thickness: This measure of adiposity was also significantly greater in newborns of mothers with OSA.
- Large for Gestational Age (LGA): A higher proportion of newborns were classified as LGA in the OSA group.
What Recent Research Examines
Recent reviews examine sleep-disordered breathing in pregnancy and its relationship to maternal morbidity and fetal and neonatal outcomes. They also assess current guidelines and available treatment modalities, including their potential effects on pregnancy health. A longitudinal study enrolled women with singleton pregnancies and a body mass index of at least 27 kg/m2 and used level-III sleep apnea testing. Related research investigates intermittent-hypoxia-induced immune responses in pregnancies and offspring, while noting that OSA is more prevalent in men.
Important Study Limitations
Evidence on maternal sleep-disordered breathing and offspring growth has important methodological limitations. One study lacked information about paternal anthropometry, which has been associated with fetal growth. Another used an ambulatory sleep study rather than polysomnography, limiting detection of flow limitation and sleep fragmentation. The broader literature describes sleep-disordered breathing as a spectrum involving snoring, airflow limitation, and intermittent hypoxia, with reported prevalence figures of 33% for snoring and up to 70% for OSA in high-risk pregnancies.
Comparing the Evidence Base
Obstructive sleep apnea is described as a common sleep disorder associated with several medical conditions, increased motor vehicle-accident risk, and overall healthcare expenditure. Pregnancy-specific research has used retrospective reviews of pregnant women who underwent overnight polysomnography to investigate changes in fetal growth trajectories. These approaches differ from broader clinical discussions of OSA because they directly examine maternal sleep measurements alongside fetal growth. The available source material therefore supports comparison between general OSA burdens and pregnancy studies focused on fetal growth, without establishing a single definitive growth outcome.
What This Means for Expectant Mothers
While these findings are intriguing, it's important to remember that this is just one study. More research is needed to fully understand the mechanisms behind the link between maternal OSA and accelerated fetal growth. However, these results highlight the importance of discussing sleep health with your doctor during pregnancy. If you experience symptoms like habitual snoring, daytime sleepiness, or restless sleep, consider getting screened for OSA.
Priorities for Future Research
Future reviews are expected to integrate newer evidence on maternal morbidity, fetal and neonatal outcomes, treatment modalities, and pregnancy-health effects. Research priorities include pregnancy-specific diagnostic tools, longitudinal outcome studies, establishing OSA treatment before pregnancy, and inclusive multicentre research. These efforts are intended to support evidence-based, multidisciplinary care. Public-facing discussions also emphasize examining how even mild sleep apnea during pregnancy may affect fetal development and what actions may support a healthy pregnancy.
Pregnancy in Real-World Context
The prevalence of OSA during pregnancy is reported to be rising, and maternal OSA has been associated with hypertensive disorders of pregnancy and gestational diabetes. Its effect on the fetus, particularly fetal growth, remains an important area of investigation. The SAFER study focuses on patients with fetal growth restriction and home sleep apnoea testing-diagnosed OSA, which may increase the potential benefit of positive airway pressure but limits how broadly the findings apply. Positive airway pressure is described as a routine, safe, and effective OSA therapy in non-pregnant populations, while its pregnancy-specific benefits continue to be studied.